ACRS - Aclaris Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACRS is currently covered by 6 analysts with an average price target of $12.78. This is a potential upside of $11.19 (703.77%) from yesterday's end of day stock price of $1.59.

Aclaris Therapeutics's activity chart (see below) currently has 41 price targets and 52 ratings on display. The stock rating distribution of ACRS is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.09% with an average time for these price targets to be met of 160.45 days.

Highest price target for ACRS is $13, Lowest price target is $7, average price target is $4.83.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 23-Dec-2024. First documented stock forecast 02-Nov-2015.

Currently out of the existing stock ratings of ACRS, 10 are a BUY (50%), 10 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

3 months 7 days ago
(23-Dec-2024)

0/5 (0%)

$34.34 (396.54%)

Buy

$8

$6.41 (403.14%)

4 months 11 days ago
(19-Nov-2024)

0/3 (0%)

$3.41 (74.29%)

Buy

$7

$5.41 (340.25%)

4 months 11 days ago
(19-Nov-2024)

1/4 (25%)

$2.41 (52.51%)

315

Buy

$13

$11.41 (717.61%)

$2

4 months 12 days ago
(18-Nov-2024)

1/5 (20%)

$9.86 (314.01%)

354

Hold

$1

$-0.59 (-37.11%)

$2

1 years 3 months 12 days ago
(18-Dec-2023)

2/4 (50%)

$0.06 (6.38%)

178

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACRS (Aclaris Therapeutics) average time for price targets to be met?

On average it took 160.45 days on average for the stock forecasts to be realized with a an average price target met ratio 29.09

Which analyst has the current highest performing score on ACRS (Aclaris Therapeutics) with a proven track record?

DAVID STEINBERG

Which analyst has the most public recommendations on ACRS (Aclaris Therapeutics)?

David Steinberg has 2 price targets and 2 ratings on ACRS

Which analyst is the currently most bullish on ACRS (Aclaris Therapeutics)?

Corinne Jenkins with highest potential upside - $19.41

Which analyst is the currently most reserved on ACRS (Aclaris Therapeutics)?

Alex Thompson with lowest potential downside - -$0.59

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?